Taro Pharmaceutical Industries RX
FDA Approved Drugs
Taro Pharmaceutical Industries RX
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 108
- Latest Approval Date Jun 15, 2026
- Data Source FDA
- First Approval Date Nov 09, 1984
Company Overview
Company
Taro Pharmaceutical Industries RX
Country
U.S.A
Website
Social Profiles
Company Snapshot
Taro Pharmaceutical Industries RX
Three Skyline Drive Hawthorne, NY 10532
U.S.A
www.taro.com/ enquiries@pharmacompass.com View on MapFDA Approved Drug Records ( 108 records )
Drug Name
ACETAZOLAMIDE
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
1997-05-28
Active Ingredient
ACETAZOLAMIDE
Application Number
40195
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
1997-05-28
Regulatory Status
RX
Drug Name
ACETAZOLAMIDE
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
1997-05-28
Active Ingredient
ACETAZOLAMIDE
Application Number
40195
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
1997-05-28
Regulatory Status
RX
Drug Name
AMIODARONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2001-03-30
Active Ingredient
AMIODARONE HYDROCHLORIDE
Application Number
75424
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2001-03-30
Regulatory Status
RX
Drug Name
AMIODARONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2002-12-18
Active Ingredient
AMIODARONE HYDROCHLORIDE
Application Number
75424
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2002-12-18
Regulatory Status
RX
Drug Name
BETAMETHASONE VALERATE
Product Number
1
Dosage Form
-
Strength
0.12%
Approval Date
2017-05-24
Active Ingredient
BETAMETHASONE VALERATE
Application Number
208204
Product Number
1
Dosage Form
-
Strength
0.12%
Approval Date
2017-05-24
Regulatory Status
RX
Drug Name
BUMETANIDE
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
2023-07-24
Active Ingredient
BUMETANIDE
Application Number
213458
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
2023-07-24
Regulatory Status
RX
Drug Name
BUMETANIDE
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
2023-07-24
Active Ingredient
BUMETANIDE
Application Number
213458
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
2023-07-24
Regulatory Status
RX
Drug Name
BUMETANIDE
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
2023-07-24
Active Ingredient
BUMETANIDE
Application Number
213458
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
2023-07-24
Regulatory Status
RX
Drug Name
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Product Number
1
Dosage Form
-
Strength
300MG;50MG;40MG
Approval Date
2020-07-01
Active Ingredient
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Application Number
213046
Product Number
1
Dosage Form
-
Strength
300MG;50MG;40MG
Approval Date
2020-07-01
Regulatory Status
RX
Drug Name
CARBAMAZEPINE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1996-10-03
Active Ingredient
CARBAMAZEPINE
Application Number
74649
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1996-10-03
Regulatory Status
RX
Drug Name
CARBAMAZEPINE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2009-03-31
Active Ingredient
CARBAMAZEPINE
Application Number
78115
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2009-03-31
Regulatory Status
RX
Drug Name
CARBAMAZEPINE
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2009-03-31
Active Ingredient
CARBAMAZEPINE
Application Number
78115
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
2009-03-31
Regulatory Status
RX
Drug Name
CARBAMAZEPINE
Product Number
3
Dosage Form
-
Strength
400MG
Approval Date
2009-03-31
Active Ingredient
CARBAMAZEPINE
Application Number
78115
Product Number
3
Dosage Form
-
Strength
400MG
Approval Date
2009-03-31
Regulatory Status
RX
Drug Name
CETIRIZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2008-06-20
Active Ingredient
CETIRIZINE HYDROCHLORIDE
Application Number
76601
Product Number
1
Dosage Form
-
Strength
5MG/5ML
Approval Date
2008-06-20
Regulatory Status
RX
Drug Name
CLINDAMYCIN PHOSPHATE
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2020-03-11
Active Ingredient
CLINDAMYCIN PHOSPHATE
Application Number
210004
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2020-03-11
Regulatory Status
RX
Drug Name
CLOBAZAM
Product Number
1
Dosage Form
-
Strength
2.5MG/ML
Approval Date
2019-04-15
Active Ingredient
CLOBAZAM
Application Number
210978
Product Number
1
Dosage Form
-
Strength
2.5MG/ML
Approval Date
2019-04-15
Regulatory Status
RX
Drug Name
CLOBETASOL PROPIONATE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2018-10-04
Active Ingredient
CLOBETASOL PROPIONATE
Application Number
208779
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2018-10-04
Regulatory Status
RX
Drug Name
CLOCORTOLONE PIVALATE
Product Number
1
Dosage Form
-
Strength
0.1%
Approval Date
2020-04-21
Active Ingredient
CLOCORTOLONE PIVALATE
Application Number
206370
Product Number
1
Dosage Form
-
Strength
0.1%
Approval Date
2020-04-21
Regulatory Status
RX
Drug Name
CLOMIPRAMINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
1996-12-31
Active Ingredient
CLOMIPRAMINE HYDROCHLORIDE
Application Number
74694
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
1996-12-31
Regulatory Status
RX
Drug Name
CLOMIPRAMINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
1996-12-31
Active Ingredient
CLOMIPRAMINE HYDROCHLORIDE
Application Number
74694
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
1996-12-31
Regulatory Status
RX
Drug Name
CLOMIPRAMINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
75MG
Approval Date
1996-12-31
Active Ingredient
CLOMIPRAMINE HYDROCHLORIDE
Application Number
74694
Product Number
3
Dosage Form
-
Strength
75MG
Approval Date
1996-12-31
Regulatory Status
RX
Drug Name
CLORAZEPATE DIPOTASSIUM
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2000-04-27
Active Ingredient
CLORAZEPATE DIPOTASSIUM
Application Number
75731
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2000-04-27
Regulatory Status
RX
Drug Name
CLORAZEPATE DIPOTASSIUM
Product Number
2
Dosage Form
-
Strength
7.5MG
Approval Date
2000-04-27
Active Ingredient
CLORAZEPATE DIPOTASSIUM
Application Number
75731
Product Number
2
Dosage Form
-
Strength
7.5MG
Approval Date
2000-04-27
Regulatory Status
RX
Drug Name
CLORAZEPATE DIPOTASSIUM
Product Number
3
Dosage Form
-
Strength
3.75MG
Approval Date
2000-04-27
Active Ingredient
CLORAZEPATE DIPOTASSIUM
Application Number
75731
Product Number
3
Dosage Form
-
Strength
3.75MG
Approval Date
2000-04-27
Regulatory Status
RX
Drug Name
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE;1%
Approval Date
2001-05-29
Active Ingredient
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
Application Number
75673
Product Number
1
Dosage Form
-
Strength
EQ 0.05% BASE;1%
Approval Date
2001-05-29
Regulatory Status
RX
Drug Name
DEFERIPRONE
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2019-02-08
Active Ingredient
DEFERIPRONE
Application Number
208800
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2019-02-08
Regulatory Status
RX
Drug Name
DEFERIPRONE
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2023-11-22
Active Ingredient
DEFERIPRONE
Application Number
208800
Product Number
2
Dosage Form
-
Strength
1GM
Approval Date
2023-11-22
Regulatory Status
RX
Drug Name
DESLORATADINE
Product Number
1
Dosage Form
-
Strength
0.5MG/ML
Approval Date
2016-05-26
Active Ingredient
DESLORATADINE
Application Number
202936
Product Number
1
Dosage Form
-
Strength
0.5MG/ML
Approval Date
2016-05-26
Regulatory Status
RX
Drug Name
DESONIDE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2014-10-31
Active Ingredient
DESONIDE
Application Number
202161
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2014-10-31
Regulatory Status
RX
Drug Name
DICLOFENAC POTASSIUM
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2024-06-14
Active Ingredient
DICLOFENAC POTASSIUM
Application Number
218011
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2024-06-14
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 3MG BASE
Approval Date
2025-08-06
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
219058
Product Number
1
Dosage Form
-
Strength
EQ 3MG BASE
Approval Date
2025-08-06
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 6MG BASE
Approval Date
2025-08-06
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
219058
Product Number
2
Dosage Form
-
Strength
EQ 6MG BASE
Approval Date
2025-08-06
Regulatory Status
RX
Drug Name
ENALAPRIL MALEATE
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2001-01-23
Active Ingredient
ENALAPRIL MALEATE
Application Number
75657
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2001-01-23
Regulatory Status
RX
Drug Name
ENALAPRIL MALEATE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2001-01-23
Active Ingredient
ENALAPRIL MALEATE
Application Number
75657
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2001-01-23
Regulatory Status
RX
Drug Name
ENALAPRIL MALEATE
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2001-01-23
Active Ingredient
ENALAPRIL MALEATE
Application Number
75657
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2001-01-23
Regulatory Status
RX
Drug Name
ENALAPRIL MALEATE
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2001-01-23
Active Ingredient
ENALAPRIL MALEATE
Application Number
75657
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2001-01-23
Regulatory Status
RX
Drug Name
ETODOLAC
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1998-04-30
Active Ingredient
ETODOLAC
Application Number
75078
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1998-04-30
Regulatory Status
RX
Drug Name
ETODOLAC
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
1998-04-30
Active Ingredient
ETODOLAC
Application Number
75078
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
1998-04-30
Regulatory Status
RX
Drug Name
ETODOLAC
Product Number
1
Dosage Form
-
Strength
400MG
Approval Date
2003-03-13
Active Ingredient
ETODOLAC
Application Number
76174
Product Number
1
Dosage Form
-
Strength
400MG
Approval Date
2003-03-13
Regulatory Status
RX
Drug Name
ETODOLAC
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2003-03-13
Active Ingredient
ETODOLAC
Application Number
76174
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2003-03-13
Regulatory Status
RX
Drug Name
ETODOLAC
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
2003-03-13
Active Ingredient
ETODOLAC
Application Number
76174
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
2003-03-13
Regulatory Status
RX
Drug Name
EXTENDED PHENYTOIN SODIUM
Product Number
1
Dosage Form
-
Strength
100MG EXTENDED
Approval Date
2006-09-05
Active Ingredient
PHENYTOIN SODIUM
Application Number
40684
Product Number
1
Dosage Form
-
Strength
100MG EXTENDED
Approval Date
2006-09-05
Regulatory Status
RX
Drug Name
FELBAMATE
Product Number
1
Dosage Form
-
Strength
600MG/5ML
Approval Date
2017-06-16
Active Ingredient
FELBAMATE
Application Number
206314
Product Number
1
Dosage Form
-
Strength
600MG/5ML
Approval Date
2017-06-16
Regulatory Status
RX
Drug Name
FELBAMATE
Product Number
1
Dosage Form
-
Strength
400MG
Approval Date
2017-04-20
Active Ingredient
FELBAMATE
Application Number
207093
Product Number
1
Dosage Form
-
Strength
400MG
Approval Date
2017-04-20
Regulatory Status
RX
Drug Name
FELBAMATE
Product Number
2
Dosage Form
-
Strength
600MG
Approval Date
2017-04-20
Active Ingredient
FELBAMATE
Application Number
207093
Product Number
2
Dosage Form
-
Strength
600MG
Approval Date
2017-04-20
Regulatory Status
RX
Drug Name
FLUOCINONIDE EMULSIFIED BASE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1989-01-19
Active Ingredient
FLUOCINONIDE
Application Number
72494
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1989-01-19
Regulatory Status
RX
Drug Name
FLUOROURACIL
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
2003-11-05
Active Ingredient
FLUOROURACIL
Application Number
76526
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
2003-11-05
Regulatory Status
RX
Drug Name
FLUOROURACIL
Product Number
2
Dosage Form
-
Strength
5%
Approval Date
2003-11-05
Active Ingredient
FLUOROURACIL
Application Number
76526
Product Number
2
Dosage Form
-
Strength
5%
Approval Date
2003-11-05
Regulatory Status
RX
Drug Name
FLUOROURACIL
Product Number
1
Dosage Form
-
Strength
5%
Approval Date
2010-03-05
Active Ingredient
FLUOROURACIL
Application Number
90368
Product Number
1
Dosage Form
-
Strength
5%
Approval Date
2010-03-05
Regulatory Status
RX
Drug Name
FLUPHENAZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2022-04-14
Active Ingredient
FLUPHENAZINE HYDROCHLORIDE
Application Number
215674
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2022-04-14
Regulatory Status
RX
Drug Name
FLUPHENAZINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
2.5MG
Approval Date
2022-04-14
Active Ingredient
FLUPHENAZINE HYDROCHLORIDE
Application Number
215674
Product Number
2
Dosage Form
-
Strength
2.5MG
Approval Date
2022-04-14
Regulatory Status
RX
Drug Name
FLUPHENAZINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
2022-04-14
Active Ingredient
FLUPHENAZINE HYDROCHLORIDE
Application Number
215674
Product Number
3
Dosage Form
-
Strength
5MG
Approval Date
2022-04-14
Regulatory Status
RX
Drug Name
FLUPHENAZINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2022-04-14
Active Ingredient
FLUPHENAZINE HYDROCHLORIDE
Application Number
215674
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2022-04-14
Regulatory Status
RX
Drug Name
HYDROCORTISONE
Product Number
1
Dosage Form
-
Strength
2.5%
Approval Date
1984-11-09
Active Ingredient
HYDROCORTISONE
Application Number
88799
Product Number
1
Dosage Form
-
Strength
2.5%
Approval Date
1984-11-09
Regulatory Status
RX
Drug Name
HYDROCORTISONE AND ACETIC ACID
Product Number
1
Dosage Form
-
Strength
2%;1%
Approval Date
1985-03-04
Active Ingredient
ACETIC ACID, GLACIAL; HYDROCORTISONE
Application Number
88759
Product Number
1
Dosage Form
-
Strength
2%;1%
Approval Date
1985-03-04
Regulatory Status
RX
Drug Name
HYDROCORTISONE BUTYRATE
Product Number
1
Dosage Form
-
Strength
0.1%
Approval Date
2004-12-27
Active Ingredient
HYDROCORTISONE BUTYRATE
Application Number
76842
Product Number
1
Dosage Form
-
Strength
0.1%
Approval Date
2004-12-27
Regulatory Status
RX
Drug Name
IMIQUIMOD
Product Number
1
Dosage Form
-
Strength
5%
Approval Date
2011-04-15
Active Ingredient
IMIQUIMOD
Application Number
200173
Product Number
1
Dosage Form
-
Strength
5%
Approval Date
2011-04-15
Regulatory Status
RX
Drug Name
IMIQUIMOD
Product Number
1
Dosage Form
-
Strength
3.75%
Approval Date
2021-01-26
Active Ingredient
IMIQUIMOD
Application Number
205971
Product Number
1
Dosage Form
-
Strength
3.75%
Approval Date
2021-01-26
Regulatory Status
RX
Drug Name
KETOCONAZOLE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1999-06-15
Active Ingredient
KETOCONAZOLE
Application Number
75319
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
1999-06-15
Regulatory Status
RX
Drug Name
LACTULOSE
Product Number
1
Dosage Form
-
Strength
10GM/15ML
Approval Date
2024-12-13
Active Ingredient
LACTULOSE
Application Number
218858
Product Number
1
Dosage Form
-
Strength
10GM/15ML
Approval Date
2024-12-13
Regulatory Status
RX
Drug Name
LAMOTRIGINE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2025-10-07
Active Ingredient
LAMOTRIGINE
Application Number
219677
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2025-10-07
Regulatory Status
RX
Drug Name
LAMOTRIGINE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2025-10-07
Active Ingredient
LAMOTRIGINE
Application Number
219677
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2025-10-07
Regulatory Status
RX
Drug Name
LAMOTRIGINE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2025-10-07
Active Ingredient
LAMOTRIGINE
Application Number
219677
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2025-10-07
Regulatory Status
RX
Drug Name
LAMOTRIGINE
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
2025-10-07
Active Ingredient
LAMOTRIGINE
Application Number
219677
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
2025-10-07
Regulatory Status
RX
Drug Name
LEVETIRACETAM
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2009-02-10
Active Ingredient
LEVETIRACETAM
Application Number
78774
Product Number
1
Dosage Form
-
Strength
100MG/ML
Approval Date
2009-02-10
Regulatory Status
RX
Drug Name
METRONIDAZOLE
Product Number
1
Dosage Form
-
Strength
0.75%
Approval Date
2006-07-18
Active Ingredient
METRONIDAZOLE
Application Number
77819
Product Number
1
Dosage Form
-
Strength
0.75%
Approval Date
2006-07-18
Regulatory Status
RX
Drug Name
METRONIDAZOLE
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2017-03-14
Active Ingredient
METRONIDAZOLE
Application Number
204651
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2017-03-14
Regulatory Status
RX
Drug Name
NORTRIPTYLINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2000-05-08
Active Ingredient
NORTRIPTYLINE HYDROCHLORIDE
Application Number
75520
Product Number
1
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2000-05-08
Regulatory Status
RX
Drug Name
NORTRIPTYLINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2000-05-08
Active Ingredient
NORTRIPTYLINE HYDROCHLORIDE
Application Number
75520
Product Number
2
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2000-05-08
Regulatory Status
RX
Drug Name
NORTRIPTYLINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2000-05-08
Active Ingredient
NORTRIPTYLINE HYDROCHLORIDE
Application Number
75520
Product Number
3
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2000-05-08
Regulatory Status
RX
Drug Name
NORTRIPTYLINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2000-05-08
Active Ingredient
NORTRIPTYLINE HYDROCHLORIDE
Application Number
75520
Product Number
4
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2000-05-08
Regulatory Status
RX
Drug Name
OXCARBAZEPINE
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2007-11-15
Active Ingredient
OXCARBAZEPINE
Application Number
77801
Product Number
1
Dosage Form
-
Strength
150MG
Approval Date
2007-11-15
Regulatory Status
RX
Drug Name
OXCARBAZEPINE
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2007-11-15
Active Ingredient
OXCARBAZEPINE
Application Number
77801
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2007-11-15
Regulatory Status
RX
Drug Name
OXCARBAZEPINE
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
2007-11-15
Active Ingredient
OXCARBAZEPINE
Application Number
77801
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
2007-11-15
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2025-11-25
Active Ingredient
PERAMPANEL
Application Number
209538
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2025-11-25
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
2025-11-25
Active Ingredient
PERAMPANEL
Application Number
209538
Product Number
2
Dosage Form
-
Strength
4MG
Approval Date
2025-11-25
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
3
Dosage Form
-
Strength
6MG
Approval Date
2025-11-25
Active Ingredient
PERAMPANEL
Application Number
209538
Product Number
3
Dosage Form
-
Strength
6MG
Approval Date
2025-11-25
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
4
Dosage Form
-
Strength
8MG
Approval Date
2025-11-25
Active Ingredient
PERAMPANEL
Application Number
209538
Product Number
4
Dosage Form
-
Strength
8MG
Approval Date
2025-11-25
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
5
Dosage Form
-
Strength
10MG
Approval Date
2025-11-25
Active Ingredient
PERAMPANEL
Application Number
209538
Product Number
5
Dosage Form
-
Strength
10MG
Approval Date
2025-11-25
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
6
Dosage Form
-
Strength
12MG
Approval Date
2025-11-25
Active Ingredient
PERAMPANEL
Application Number
209538
Product Number
6
Dosage Form
-
Strength
12MG
Approval Date
2025-11-25
Regulatory Status
RX
Drug Name
PERAMPANEL
Product Number
1
Dosage Form
-
Strength
0.5MG/ML
Approval Date
2026-06-15
Active Ingredient
PERAMPANEL
Application Number
219052
Product Number
1
Dosage Form
-
Strength
0.5MG/ML
Approval Date
2026-06-15
Regulatory Status
RX
Drug Name
PHENYTOIN
Product Number
1
Dosage Form
-
Strength
125MG/5ML
Approval Date
2004-03-08
Active Ingredient
PHENYTOIN
Application Number
40521
Product Number
1
Dosage Form
-
Strength
125MG/5ML
Approval Date
2004-03-08
Regulatory Status
RX
Drug Name
PHENYTOIN
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2014-04-17
Active Ingredient
PHENYTOIN
Application Number
200565
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2014-04-17
Regulatory Status
RX
Drug Name
POTASSIUM CHLORIDE
Product Number
1
Dosage Form
-
Strength
20MEQ/15ML
Approval Date
2025-07-22
Active Ingredient
POTASSIUM CHLORIDE
Application Number
218960
Product Number
1
Dosage Form
-
Strength
20MEQ/15ML
Approval Date
2025-07-22
Regulatory Status
RX
Drug Name
RIVAROXABAN
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2025-03-03
Active Ingredient
RIVAROXABAN
Application Number
208557
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2025-03-03
Regulatory Status
RX
Drug Name
RIVAROXABAN
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2025-10-07
Active Ingredient
RIVAROXABAN
Application Number
208557
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2025-10-07
Regulatory Status
RX
Drug Name
RIVAROXABAN
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
2025-10-07
Active Ingredient
RIVAROXABAN
Application Number
208557
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
2025-10-07
Regulatory Status
RX
Drug Name
RIVAROXABAN
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2025-10-07
Active Ingredient
RIVAROXABAN
Application Number
208557
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2025-10-07
Regulatory Status
RX
Drug Name
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Product Number
1
Dosage Form
-
Strength
45MG/5ML (9MG/ML)
Approval Date
2006-08-11
Active Ingredient
SODIUM CHLORIDE
Application Number
77407
Product Number
1
Dosage Form
-
Strength
45MG/5ML (9MG/ML)
Approval Date
2006-08-11
Regulatory Status
RX
Drug Name
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Product Number
2
Dosage Form
-
Strength
90MG/10ML (9MG/ML)
Approval Date
2006-08-11
Active Ingredient
SODIUM CHLORIDE
Application Number
77407
Product Number
2
Dosage Form
-
Strength
90MG/10ML (9MG/ML)
Approval Date
2006-08-11
Regulatory Status
RX
Drug Name
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
Product Number
1
Dosage Form
-
Strength
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT
Approval Date
2024-03-19
Active Ingredient
MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
Application Number
206431
Product Number
1
Dosage Form
-
Strength
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT
Approval Date
2024-03-19
Regulatory Status
RX
Drug Name
TERIL
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2004-09-20
Active Ingredient
CARBAMAZEPINE
Application Number
76729
Product Number
1
Dosage Form
-
Strength
100MG/5ML
Approval Date
2004-09-20
Regulatory Status
RX
Drug Name
TICAGRELOR
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2025-10-28
Active Ingredient
TICAGRELOR
Application Number
211498
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2025-10-28
Regulatory Status
RX
Drug Name
TICAGRELOR
Product Number
2
Dosage Form
-
Strength
90MG
Approval Date
2025-10-28
Active Ingredient
TICAGRELOR
Application Number
211498
Product Number
2
Dosage Form
-
Strength
90MG
Approval Date
2025-10-28
Regulatory Status
RX
Drug Name
TOPICORT
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1985-01-17
Active Ingredient
DESOXIMETASONE
Application Number
18594
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1985-01-17
Regulatory Status
RX
Drug Name
TOPICORT
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
1990-11-30
Active Ingredient
DESOXIMETASONE
Application Number
73193
Product Number
1
Dosage Form
-
Strength
0.25%
Approval Date
1990-11-30
Regulatory Status
RX
Drug Name
TOPICORT
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1990-11-30
Active Ingredient
DESOXIMETASONE
Application Number
73210
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1990-11-30
Regulatory Status
RX
Drug Name
TOPICORT
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1998-07-14
Active Ingredient
DESOXIMETASONE
Application Number
74904
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1998-07-14
Regulatory Status
RX
Drug Name
TRIAMCINOLONE ACETONIDE
Product Number
1
Dosage Form
-
Strength
0.1%
Approval Date
1997-11-26
Active Ingredient
TRIAMCINOLONE ACETONIDE
Application Number
40039
Product Number
1
Dosage Form
-
Strength
0.1%
Approval Date
1997-11-26
Regulatory Status
RX
Drug Name
WARFARIN SODIUM
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
1999-07-15
Active Ingredient
WARFARIN SODIUM
Application Number
40301
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
1999-07-15
Regulatory Status
RX
Drug Name
WARFARIN SODIUM
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
1999-07-15
Active Ingredient
WARFARIN SODIUM
Application Number
40301
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
1999-07-15
Regulatory Status
RX
Drug Name
WARFARIN SODIUM
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
1999-07-15
Active Ingredient
WARFARIN SODIUM
Application Number
40301
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
1999-07-15
Regulatory Status
RX
Drug Name
WARFARIN SODIUM
Product Number
4
Dosage Form
-
Strength
2.5MG
Approval Date
1999-07-15
Active Ingredient
WARFARIN SODIUM
Application Number
40301
Product Number
4
Dosage Form
-
Strength
2.5MG
Approval Date
1999-07-15
Regulatory Status
RX
Drug Name
WARFARIN SODIUM
Product Number
5
Dosage Form
-
Strength
3MG
Approval Date
1999-07-15
Active Ingredient
WARFARIN SODIUM
Application Number
40301
Product Number
5
Dosage Form
-
Strength
3MG
Approval Date
1999-07-15
Regulatory Status
RX
Drug Name
WARFARIN SODIUM
Product Number
6
Dosage Form
-
Strength
4MG
Approval Date
1999-07-15
Active Ingredient
WARFARIN SODIUM
Application Number
40301
Product Number
6
Dosage Form
-
Strength
4MG
Approval Date
1999-07-15
Regulatory Status
RX
Drug Name
WARFARIN SODIUM
Product Number
7
Dosage Form
-
Strength
5MG
Approval Date
1999-07-15
Active Ingredient
WARFARIN SODIUM
Application Number
40301
Product Number
7
Dosage Form
-
Strength
5MG
Approval Date
1999-07-15
Regulatory Status
RX
Drug Name
WARFARIN SODIUM
Product Number
8
Dosage Form
-
Strength
6MG
Approval Date
1999-07-15
Active Ingredient
WARFARIN SODIUM
Application Number
40301
Product Number
8
Dosage Form
-
Strength
6MG
Approval Date
1999-07-15
Regulatory Status
RX
Drug Name
WARFARIN SODIUM
Product Number
9
Dosage Form
-
Strength
7.5MG
Approval Date
1999-07-15
Active Ingredient
WARFARIN SODIUM
Application Number
40301
Product Number
9
Dosage Form
-
Strength
7.5MG
Approval Date
1999-07-15
Regulatory Status
RX
Drug Status Breakdown
108 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ACETAZOLAMIDE
Application Number
40195
Product Number
1
Active Ingredient
ACETAZOLAMIDE
Dosage Form
-
Strength
125MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.